DrugPatentWatch Database Preview
Drugs in Development Information for Ambroxol
» See Plans and Pricing
What is the development status for investigational drug Ambroxol?
Ambroxol is an investigational drug.
There have been 24 clinical trials for Ambroxol.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2007.
The most common disease conditions in clinical trials are Pharyngitis, Dementia, and Parkinson Disease. The leading clinical trial sponsors are Boehringer Ingelheim, Hyundai Pharmaceutical Co., LTD., and Lawson Health Research Institute.
Summary for Ambroxol
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,257 |
| WIPO Patent Applications | 1,767 |
| Japanese Patent Applications | 883 |
| Clinical Trial Progress | Phase 3 (2007-08-01) |
| Vendors | 69 |
Recent Clinical Trials for Ambroxol
| Title | Sponsor | Phase |
|---|---|---|
| Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial | Helse-Bergen HF | Phase 2 |
| Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial | KLINBEFORSK | Phase 2 |
| Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial | Helse Fonna | Phase 2 |
Clinical Trial Summary for Ambroxol
Top disease conditions for Ambroxol
Top clinical trial sponsors for Ambroxol
US Patents for Ambroxol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
